Abstract: . . .  the effectiveness of PSA and DRE screening in preventing deaths from prostate cancer . Data from medical records will be analyzed to determine whether patients who died of prostate cancer were less likely to have had PSA or DRE screening than patients who did not die of prostate cancer . Data analysis will be completed this year. • Using formative research, including focus group findings, to develop an educational video for men who are thinking about being screened for prostate cancer . The video seeks to increase men’s knowledge of the prostate gland and prostate cancer , provide them with basic facts about prostate cancer screening, encourage them to discuss screening with their health professionals, and educate them so they can make an informed decision about screening. • Studying physician-patient communication about prostate cancer screening with PSA and DRE among underserved minority men. What patients say they heard or discussed with their physician during their visit will be compared with what the physicians say they disclosed. Results will highlight gaps in physician-patient communication, which will help in developing culturally appropriate interventions to improve men’s knowledge about prostate cancer screening. • Collaborating with the National Cancer Institute on the cancer control portion of the National Health Interview Survey for the year 2000. For the first time, national data are available on the use of PSA testing in a national sample of U.S. men, the communication of risks and benefits of testing, and factors that influence use of the PSA test.  . . .
--2429,1,1214,1683,12144